Literature DB >> 936708

[A suggestion for the evaluation of the antepartal cardiotocogram (author's transl)].

W M Fischer, I Stude, H Brandt.   

Abstract

An evaluation scale for the antepartal cardiotocogram is suggested which is intentionally based on the Apgar scale. Five criteria were evaluated: three characteristics of the basal fetal heart rate and two characteristic, recognized alterations in heart rate. In regard to the interpretation of the basal heart rate, level, range and number of flat readings per minute are significant for the prognosis. Alterations in heart rate permit a prognostic statement depending on the form and type of the acceleration and deceleration 0-2 points are given for every characteristic so that the index can vary from 0 to 10 points. The condition of the fetus is physiologic when the index is between 8-10, the prognosis is questionable when the index is between 5 and 7 and the condition of the fetus is critical when it is 4 or lower.

Mesh:

Year:  1976        PMID: 936708

Source DB:  PubMed          Journal:  Z Geburtshilfe Perinatol        ISSN: 0300-967X


  4 in total

1.  [Epidural anesthesia for fetoscopy : Retrospective analysis of a one-year cohort].

Authors:  N Kiefer; S F Suter; C Berg; U Gembruch; S U Weber
Journal:  Anaesthesist       Date:  2016-12-22       Impact factor: 1.041

2.  [Patterns of fetal heart frequency during the second stage of labour and expulsion period--typical patterns, frequency, risk of acidosis and evaluation (author's transl)].

Authors:  C M Schlotter; E Jäger; G Wössner; A Scheub
Journal:  Arch Gynecol       Date:  1979-03-28

3.  May high oxygen affinity of maternal hemoglobin cause fetal growth retardation?

Authors:  A Ortner; H Zech; E Humpeler; H Mairbaeurl
Journal:  Arch Gynecol       Date:  1983

Review 4.  Adaptation of Maternal-Fetal Physiology to Exercise in Pregnancy: The Basis of Guidelines for Physical Activity in Pregnancy.

Authors:  Edward R Newton; Linda May
Journal:  Clin Med Insights Womens Health       Date:  2017-02-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.